I am a medical epidemiologist (MD in 1988 at Paris V, specialisation in rheumatology in 1990, Paris V, and DrPH from Harvard School of Public Health in 1993) specialized in infectious diseases epidemiology. After working at WHO at the clinical research unit of the Global Program on AIDS (1993-1994), I spent five years in Ethiopia and two years in the Netherlands working as the Program Manager of the Ethio-Netherlands AIDS Research Project (1994-2001). In 2002, I joined Institut Pasteur to launch the Emerging Diseases Epidemiology unit. There, my focus has been on viral hepatitis C (North-Coordinator of the ANRS research site on viral hepatitis; www.hepnile.org) and emerging infections such as the SARS (Scientific Coordinator of the EPISARS project which aimed prevent the re-emergence of SARS through the control of its animal reservoir) and the MERS-CoV. I also have a strong teaching involvement, as co-Director and founder of the Pasteur-Cnam School of Public Health (http://ecole-pasteur.cnam.fr), and coordinator of a master in public health with strong focus on infectious diseases. In 2014, I was appointed as Director of the newly created Pasteur Centre for Global Health Research and Education.
Click to view graph
Connections
Click to view timeline
Timeline
About
Courses
Viral Outbreaks and Pandemics, A One Health Approach MOOC
Understand why viral outbreaks and pandemics are becoming more frequent and how the world is learning to manage emerging infections in a one health approach. The MOOC is directed by Arnaud Fontanet, Pierre-Emmanuel Ceccaldi, […]
2023-12-18 00:00:00
2025-02-12 00:00:00
Europe/Paris
Viral Outbreaks and Pandemics, A One Health Approach MOOC
Understand why viral outbreaks and pandemics are becoming more frequent and how the world is learning to manage emerging infections in a one health approach. The MOOC is directed by Arnaud Fontanet, Pierre-Emmanuel Ceccaldi, […]
Viral Hepatitis MOOC
In this MOOC, you will find the latest developments on the intimate structure and pathophysiology of hepatic viruses, as well as the epidemiology and clinical courses of hepatitis. Register on : https://www.fun-mooc.fr/en/courses/viral-hepatitis/ Hepatitis is an […]
2024-04-09 08:00:00
2025-04-08 20:00:00
Europe/Paris
Viral Hepatitis MOOC
In this MOOC, you will find the latest developments on the intimate structure and pathophysiology of hepatic viruses, as well as the epidemiology and clinical courses of hepatitis. Register on : https://www.fun-mooc.fr/en/courses/viral-hepatitis/ Hepatitis is an […]
Transversal Projects
Projects
Former Teams
Publications
Download-
2024Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France, Vaccine, 2024, S0264-410X (24), pp.00438-9. ⟨10.1016/j.vaccine.2024.04.024⟩.
-
2023Risk of SARS-CoV-2 Infection Among Households With Children in France, 2020-2022., JAMA Netw Open 2023 Sep; 6(9): e2334084.
-
2023Investigation of a mpox outbreak in Central African Republic, 2021-2022., One Health 2023 Jun; 16(): 100523.
-
2023Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021., Euro Surveill 2023 Jun; 28(25): .
-
2023SARS-CoV-2 self-test uptake and factors associated with self-testing during Omicron BA.1 and BA.2 waves in France, January to May 2022., Euro Surveill 2023 May; 28(18): .
-
2023SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study., Lancet Microbe 2023 Apr; (): .
-
2023Rapid emergence of extensively drug-resistant Shigella sonnei in France., Nat Commun 2023 Jan; 14(1): 462.
-
2022Consequences of In Utero Zika Virus Exposure and Adverse Pregnancy and Early Childhood Outcomes: A Prospective Cohort Study., Viruses 2022 Dec; 14(12): .
-
2022National Monkeypox Surveillance, Central African Republic, 2001-2021., Emerging Infectious Diseases, 2022, 28 (12), pp.2435-2445. ⟨10.3201/eid2812.220897⟩.
-
2022Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
-
+View full list of publications